Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)
China · Delayed Price · Currency is CNY 17.06
-0.54 (-3.07%)
At close: Mar 19, 2026
SHA:688553 Revenue
In the year 2025, Sichuan Huiyu Pharmaceutical had annual revenue of 998.15M CNY, down -8.79%. Sichuan Huiyu Pharmaceutical had revenue of 256.39M in the quarter ending December 31, 2025, with 5.71% growth.
Revenue
998.15M
Revenue Growth
-8.79%
P/S Ratio
7.20
Revenue / Employee
722.25K
Employees
1,331
Market Cap
7.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 998.15M | -96.24M | -8.79% |
| Dec 31, 2024 | 1.09B | 167.31M | 18.05% |
| Dec 31, 2023 | 927.08M | -566.19M | -37.92% |
| Dec 31, 2022 | 1.49B | -330.47M | -18.12% |
| Dec 31, 2021 | 1.82B | 459.54M | 33.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Northeast Pharmaceutical Group | 6.85B |
| Cisen Pharmaceutical | 3.56B |
| Hunan Jiudian Pharmaceutical | 3.05B |
| Zhejiang Tianyu Pharmaceutical | 2.99B |
| Shandong Wit Dyne Health | 2.36B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.25B |
| Sunflower Pharmaceutical Group Co.,Ltd | 2.09B |
| Jiuzhitang | 1.94B |